Anna Russolillo

Summary

Affiliation: University of Foggia
Country: Italy

Publications

  1. ncbi Ropivacaine infusion in diabetics subject with peripheral arterial disease. A prospective study
    M N D Di Minno
    Department of Clinical and Experimental Medicine, Regional Reference Centre for Coagulation Disorders, Federico II University, Naples
    Exp Clin Endocrinol Diabetes 121:91-3. 2013
  2. ncbi Stroke prevention: from available antiplatelet drugs to novel molecular targets
    Matteo Nicola Dario Di Minno
    Department of Clinical and Experimental Medicine, Regional Reference Centre for Coagulation Disorders, Federico II University, Naples, Via S Pansini 5, 80131 Napoli, Italy
    Curr Drug Targets 14:3-12. 2013
  3. ncbi Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease
    Matteo Nicola Dario Di Minno
    Department of Clinical and Experimental Medicine, Regional Reference Centre for Coagulation Disorders, Federico II University, 80131 Naples, Italy
    World J Gastroenterol 18:5839-47. 2012
  4. ncbi Obesity and the prediction of minimal disease activity: a prospective study in psoriatic arthritis
    Matteo Nicola Dario Di Minno
    Federico II University, Naples, Italy
    Arthritis Care Res (Hoboken) 65:141-7. 2013
  5. ncbi Hepatic steatosis and disease activity in subjects with psoriatic arthritis receiving tumor necrosis factor-α blockers
    Matteo Nicola Dario Di Minno
    Department of Clinical and Experimental Medicine, Regional Reference Centre for Coagulation Disorders, Rheumatology Research Unit, Psoriatic Arthritis Clinic, Federico II University, Naples, Italy
    J Rheumatol 39:1042-6. 2012
  6. ncbi Aspirin resistance, platelet turnover, and diabetic angiopathy: a 2011 update
    Matteo Nicola Dario Di Minno
    Department of Clinical Experimental Medicine, Regional Reference Centre for Coagulation Disorders Napoli, Italy
    Thromb Res 129:341-4. 2012
  7. ncbi Platelet reactivity and disease activity in subjects with psoriatic arthritis
    Matteo Nicola Dario Di Minno
    Department of Clinical and Experimental Medicine, Reference Centre for Coagulation Disorders, Federico II University, Naples, Italy
    J Rheumatol 39:334-6. 2012
  8. ncbi Alcohol dosing and the heart: updating clinical evidence
    Matteo Nicola Dario Di Minno
    Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy
    Semin Thromb Hemost 37:875-84. 2011
  9. ncbi Perioperative handling of patients on antiplatelet therapy with need for surgery
    Matteo Nicola Dario Di Minno
    Department of Experimental and Clinical Medicine, Federico II University, Via Sergio Pansini 5, 80131 Naples, Italy
    Intern Emerg Med 4:279-88. 2009
  10. ncbi Carotid intima-media thickness in psoriatic arthritis: differences between tumor necrosis factor-α blockers and traditional disease-modifying antirheumatic drugs
    Matteo Nicola Dario Di Minno
    Department of Clinical and Experimental Medicine, Regional Reference Centre for Coagulation Disorders, Federico II University, Via S Pansini 5, 80131, Naples, Italy
    Arterioscler Thromb Vasc Biol 31:705-12. 2011

Detail Information

Publications22

  1. ncbi Ropivacaine infusion in diabetics subject with peripheral arterial disease. A prospective study
    M N D Di Minno
    Department of Clinical and Experimental Medicine, Regional Reference Centre for Coagulation Disorders, Federico II University, Naples
    Exp Clin Endocrinol Diabetes 121:91-3. 2013
    ..30-day peridural analgesia with ropivacaine is a valuable therapeutic option in severe peripheral limb ischemia subjects with contraindication to surgery and with pharmacological therapy failure...
  2. ncbi Stroke prevention: from available antiplatelet drugs to novel molecular targets
    Matteo Nicola Dario Di Minno
    Department of Clinical and Experimental Medicine, Regional Reference Centre for Coagulation Disorders, Federico II University, Naples, Via S Pansini 5, 80131 Napoli, Italy
    Curr Drug Targets 14:3-12. 2013
    ..In this review, after summarizing major literature data about traditional and newer antiplatelet drugs, we will specifically focus on novel potential target candidates for antiplatelet therapy...
  3. ncbi Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease
    Matteo Nicola Dario Di Minno
    Department of Clinical and Experimental Medicine, Regional Reference Centre for Coagulation Disorders, Federico II University, 80131 Naples, Italy
    World J Gastroenterol 18:5839-47. 2012
    ..According to these data, it is important to consider that most of the beneficial effects of n-3 PUFAs can also be obtained by an equilibrate nutrition program...
  4. ncbi Obesity and the prediction of minimal disease activity: a prospective study in psoriatic arthritis
    Matteo Nicola Dario Di Minno
    Federico II University, Naples, Italy
    Arthritis Care Res (Hoboken) 65:141-7. 2013
    ..We prospectively evaluated whether obesity impacts achievement of minimal disease activity (MDA) in subjects with psoriatic arthritis (PsA)...
  5. ncbi Hepatic steatosis and disease activity in subjects with psoriatic arthritis receiving tumor necrosis factor-α blockers
    Matteo Nicola Dario Di Minno
    Department of Clinical and Experimental Medicine, Regional Reference Centre for Coagulation Disorders, Rheumatology Research Unit, Psoriatic Arthritis Clinic, Federico II University, Naples, Italy
    J Rheumatol 39:1042-6. 2012
    ..We prospectively evaluated changes in HS during treatment with TNF-α blockers...
  6. ncbi Aspirin resistance, platelet turnover, and diabetic angiopathy: a 2011 update
    Matteo Nicola Dario Di Minno
    Department of Clinical Experimental Medicine, Regional Reference Centre for Coagulation Disorders Napoli, Italy
    Thromb Res 129:341-4. 2012
    ..Newer aspirin dosing and scheduling, tailored at reducing the individual patient risk related to an incomplete inhibition of platelet function by a standard aspirin dose should now be defined...
  7. ncbi Platelet reactivity and disease activity in subjects with psoriatic arthritis
    Matteo Nicola Dario Di Minno
    Department of Clinical and Experimental Medicine, Reference Centre for Coagulation Disorders, Federico II University, Naples, Italy
    J Rheumatol 39:334-6. 2012
    ..Individuals with psoriatic arthritis (PsA) are highly predisposed to vascular mortality. We evaluated the correlation between disease activity and platelet aggregation in individuals with PsA...
  8. ncbi Alcohol dosing and the heart: updating clinical evidence
    Matteo Nicola Dario Di Minno
    Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy
    Semin Thromb Hemost 37:875-84. 2011
    ..Fourth, wine (ethanol with antioxidants) exhibits significantly higher anti-inflammatory effects than gin (ethanol without polyphenols), and thus in general wine should be preferred to liquor or beer...
  9. ncbi Perioperative handling of patients on antiplatelet therapy with need for surgery
    Matteo Nicola Dario Di Minno
    Department of Experimental and Clinical Medicine, Federico II University, Via Sergio Pansini 5, 80131 Naples, Italy
    Intern Emerg Med 4:279-88. 2009
    ..Aprotinin decreases postoperative bleeding and transfusion rates in patients undergoing CABG and on clopidogrel during the days preceding surgery...
  10. ncbi Carotid intima-media thickness in psoriatic arthritis: differences between tumor necrosis factor-α blockers and traditional disease-modifying antirheumatic drugs
    Matteo Nicola Dario Di Minno
    Department of Clinical and Experimental Medicine, Regional Reference Centre for Coagulation Disorders, Federico II University, Via S Pansini 5, 80131, Naples, Italy
    Arterioscler Thromb Vasc Biol 31:705-12. 2011
    ..Tumor necrosis factor (TNF)-α, a major determinant of inflammation, is involved in atherosclerosis. Ultrasonographic carotid intima-media thickness (C-IMT) evaluation allows for subclinical atherosclerosis detection...
  11. ncbi Identifying high-risk individuals for cardiovascular disease: similarities between venous and arterial thrombosis in perspective. A 2011 update
    Matteo Nicola Dario Di Minno
    Regional Reference Centre for Coagulation Disorders, Federico II University, Naples, Italy
    Intern Emerg Med 7:9-13. 2012
    ..The value of routine screening for asymptomatic atherosclerosis (e.g. 2D echocardiography, microalbuminuria, arterial vessel ultrasonography) in these patients should be confirmed in future studies...
  12. ncbi Longer-acting factor VIII to overcome limitations in haemophilia management: the PEGylated liposomes formulation issue
    G Di Minno
    Department of Medicine, Federico II University, Reference Centre for Hemophilia and Thrombosis, Naples, Italy
    Haemophilia 16:2-6. 2010
    ..Data emerging from this phase II study will help collect relevant data to overcome current limitations in haemophilia management by employing treatment with longer-acting rFVIII...
  13. ncbi Abnormally high prevalence of major components of the metabolic syndrome in subjects with early-onset idiopathic venous thromboembolism
    M N D Di Minno
    Department of Clinical and Experimental Medicine, Reference Centre for Coagulation Disorders, Federico II University, Naples, Italy
    Thromb Res 127:193-7. 2011
    ..Although patients with idiopathic VTE are at higher than normal risk of asymptomatic atherosclerosis and of cardiovascular events, the impact of cardiovascular risk factors on VTE is poorly understood...
  14. ncbi Exploring newer cardioprotective strategies: ω-3 fatty acids in perspective
    Matteo Nicola Dario Di Minno
    Department of Experimental and Clinical Medicine, Federico II University, Naples, Italy
    Thromb Haemost 104:664-80. 2010
    ..Major experimental data provide strength (biological plausibility) for these findings, and define directions for newer clinical trials with ω-3 fatty acids...
  15. ncbi Protein C and protein S changes in GH-deficient adults on r-HGH replacement therapy: correlations with PAI-1 and t-PA plasma levels
    Matteo Nicola Dario Di Minno
    Department of Clinical and Experimental Medicine, Reference Centre for Coagulation Disorders, Federico II University, Naples, Italy
    Thromb Res 126:e434-8. 2010
    ..In GHD adults on replacement therapy with recombinant human GH (r-HGH), %Δ PAI-1 and %Δ t-PA are related to %Δ insulin changes...
  16. ncbi New anti-thrombotic drugs for stroke prevention
    Matteo Nicola Dario Di Minno
    Department of Clinical and Experimental Medicine, and Regional Reference Centre for Coagulation Disorders, Federico II University, Naples, Italy
    Curr Vasc Pharmacol 9:723-32. 2011
    ..We also discuss the major limitations of "traditional" antithrombotic drugs and report Phase III study results on safety and efficacy of new antiplatelet and anticoagulant drugs, with emphasis on stroke prevention...
  17. ncbi Cardiovascular risk in rheumatic patients: the link between inflammation and atherothrombosis
    Matteo Nicola Dario Di Minno
    Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy
    Semin Thromb Hemost 38:497-505. 2012
    ....
  18. ncbi Filling the gap between science & clinical practice: prevention of stroke recurrence
    Anna Russolillo
    Department of Experimental and Clinical Medicine, and Regional Reference Centre for Coagulation Disorders, Federico II University of Naples, Italy
    Thromb Res 129:3-8. 2012
    ....
  19. ncbi Obesity and psoriatic arthritis: from pathogenesis to clinical outcome and management
    Anna Russolillo
    Department of Clinical and Experimental Medicine, Rheumatology Research Unit, Federico II University, Naples, Italy
    Rheumatology (Oxford) 52:62-7. 2013
    ..This review assesses the relationship between obesity and PsA according to the available literature...
  20. ncbi Predictors of early minimal disease activity in patients with psoriatic arthritis treated with tumor necrosis factor-α blockers
    Salvatore Iervolino
    Department of Clinical and Experimental Medicine, Federico II University, Via Sergio Pansini 5, 80131 Naples, Italy
    J Rheumatol 39:568-73. 2012
    ..To identify predictors of early minimal disease activity in patients with psoriatic arthritis (PsA) receiving tumor necrosis factor-α (TNF-α) antagonists...
  21. ncbi Assessing joint involvement in haemophilia by clinical rheumatologic scores. A pilot study on similarities with subjects with psoriatic arthritis
    Matteo Nicola Dario Di Minno
    Department of Clinical and Experimental Medicine, Regional Reference Centre for Coagulation Disorders, Federico II University, Naples, Italy
    Clin Rheumatol 30:915-9. 2011
    ..These pilot data provide the rationale for testing a systemic involvement in haemophiliacs by means of high-tech imaging and to start early-onset prophylaxis/treatment in this setting...
  22. ncbi Direct anticoagulant drugs to overcome limitations of vitamin K antagonists. A critical appraisal of data in atrial fibrillation patients
    Matteo Nicola Dario Di Minno
    Federico II University, Regional Reference Centre for Coagulation Disorders, Department of Clinical and Experimental Medicine, Naples, Italy
    Expert Opin Emerg Drugs 18:9-23. 2013
    ..The parallel evaluation of all these data may lead to the identification of clinical and demographical criteria to choose when to switch to DACs...